Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease

Ae-Young Her,Eun-Seok Shin,Sunwon Kim,Bitna Kim,Tae-Hyun Kim,Chang-Bae Sohn,Byung Joo Choi,Yongwhi Park,Jung Rae Cho,Young-Hoon Jeong
DOI: https://doi.org/10.1186/s12933-023-01853-0
IF: 8.949
2023-05-21
Cardiovascular Diabetology
Abstract:Data on drug-coated balloon (DCB) treatment in the context of diabetes mellitus (DM) and multivessel coronary artery disease (CAD) are limited. We aimed to investigate the clinical impact of DCB-based revascularization on percutaneous coronary intervention (PCI) in patients with DM and multivessel CAD.
cardiac & cardiovascular systems,endocrinology & metabolism
What problem does this paper attempt to address?